JNJ · News · 20261021N
Guidance and Outlook
JOHNSON & JOHNSON · 2026-10-21 · Importance 57 · Surprise 60 · In source text
Johnson & Johnson raised its 2026 full-year forecast earlier in October 2026. The company now expects approximately $101.2 billion of full-year sales at the midpoint, modestly above its July 2026 outlook. Adjusted earnings per share guidance was also increased, despite third-quarter adjusted EPS declining 7.5% year over year to $2.59.
Key facts
- Johnson & Johnson raised its 2026 forecast and now expects full-year sales of about $101.2 billion at the midpoint. source
- The company raised its full-year adjusted EPS guidance. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | committed | — | Johnson & Johnson raised its 2026 forecast and now expects full-year sales of about $101.2 billion at the midpoint. |
| net_income | positive | committed | — | The company raised its full-year adjusted EPS guidance. |